Skip to main content

Table 1 Clinical features of the Patients with DMNT3A mutations

From: DNMT3A mutations and clinical features in Chinese patients with acute myeloid leukemia

No

Age

sex

FAB

Cytogenetics

WBC X10^9/L

CD33+/CD34+

DNMT3A

Chemo-response

result

7

65

F

M1

normal

36.6

6%/92%

2645 G > A

CR

Dead(12 M)

19

72

M

M2

normal

57.2

99%/32%

914 G > A

No

Dead(6 M)

22

55

M

M5

normal

112.9

99%/16%

2645 G > A

CR

Alive(SCT)

38

58

F

M5

t(6;9)

12.1

56%/55%

2096 G > A

CR

Dead(10 M)

40

56

F

M2

inv(9)

15

20%/82%

30 bp del 2502-2531

CR

Dead(SCT)

47

31

F

M5

del(13)

1.5

95%/27%

2501 C > T

N0

Dead(3 M)

48

20

F

M5

normal

30.4

4.5%/71%

2501 C > T

N0

Dead(3 M)

53

53

F

M3

t(4;17)

7.9

82%/1.6%

55 C > T

CR

Alive

56

54

F

M5

normal

2.19

95%/28%

2202 C > A

CR

Relapse(6 M)

68

52

M

M5

normal

28.8

97%/42%

2644 C > T

No

Dead(6 M)

77

76

M

M5

normal

67

No

2645 G > A Arg882His

CR

Dead(13 M)

89

76

M

M1

normal

17.3

CD13 CD34

1906 G > A 2191 T > C

NR

Dead(3 M)

94

61

F

M5

normal

132

CD7CD13CD33

2141C > G

NO

Dead(1 M)

100

46

M

M5

normal

4.5

CD13CD34

1792C > T 2375 G > A

NR

Dead(1 M)

  1. CR Complete remission, No no chemotherapy, NR not remission, M month.